topSkip to main content

Menu, Secondary

Menu Trigger

Menu

University of Illinois Urbana-Champaign

The University of Illinois System has received emergency use authorization (EUA)  from the U.S. Food and Drug Administration (FDA) for covidSHIELD, its innovative saliva-based COVID-19 test that was used on the U of I campuses to hold the virus in check by utilizing widespread testing with rapid results.
Mariam Bonyadi Camacho, a student in the medical scholars program at the University of Illinois Urbana-Champaign, co-wrote a recent report on the coronavirus’ cardiac effects, both short- and long-term
The University of Illinois Urbana-Champaign updated its COVID-19 dashboard to add more data points and greater detail.
Abrupt changes in the senses of smell and taste are commonly reported by people who contract COVID-19 and may be an early warning sign that a person has been infected.
The University of Illinois Urbana-Champaign has administered its millionth saliva-based COVID-19 test since initiating a broader management program last summer.
The University of Illinois Urbana-Champaign will shift on-campus COVID-19 testing to make the processing of results even faster.
The Grainger College of Engineering at the University of Illinois at Urbana-Champaign has completed the prototype for a mobile laboratory, called mobileSHIELD, designed to demonstrate a way to rapidly deploy I-COVID, the saliva-based test for COVID-19 developed at Illinois.
Zou and colleagues from Harvard and the University of Illinois crunched reams of data from Medicare and the National Weather Service and confirmed that more people, particularly older people with respiratory illness, were making more hospital visits on the eve of thunderstorms.
A testing protocol developed by the University of Illinois at Urbana-Champaign directly detects the coronavirus that causes COVID-19 in saliva samples.
Safer Illinois is an app for University of Illinois, Urbana-Champaign faculty members, staff and students who intend to enter university facilities this fall.